Llwytho...
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
OBJECTIVES: Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subject...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Brain Behav |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607543/ https://ncbi.nlm.nih.gov/pubmed/28948074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.776 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|